Impact Biomedical (IBO) Cash from Investing Activities Growth (3y) (2025 - 2026)

Impact Biomedical (IBO) Cash from Investing Activities Growth (3y) (2025 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Cash from Investing Growth (3y) (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	46.78%
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	66.14%
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	-44.69%
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	-39.73%
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	-246.81%
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	-177.27%
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	27.84%
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	-53.57%
10	Impact Biomedical	49.54 Mn	49.53 Mn	2,000.00	29.70%

Download Data